Corriente Advisors, LLC Tff Pharmaceuticals, Inc. Transaction History

Corriente Advisors, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 15, 2022	SELL	$6.86 - $9.65 $7 Million - $9.84 Million	-1,019,848 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$7.21 - $10.49 $7.35 Million - $10.7 Million	1,019,848 New	1,019,848 $7.87 Million
Q2 2021 Aug 16, 2021	SELL	$8.48 - $13.61 $13.3 Million - $21.3 Million	-1,565,682 Closed	0 $0
Q1 2021 May 18, 2021	BUY	$12.96 - $19.75 $2.8 Million - $4.26 Million	215,682 Added 15.98%	1,565,682 $21.2 Million
Q4 2020 Feb 16, 2021	BUY	$12.74 - $18.49 $3.71 Million - $5.38 Million	291,177 Added 27.5%	1,350,000 $19.3 Million
Q3 2020 Nov 03, 2020	BUY	$5.86 - $18.47 $6.2 Million - $19.6 Million	1,058,823 New	1,058,823 $19.6 Million

Ticker TFFP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 25,477,800
Market Cap $47.6M
Description
TFF Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, focuses on developing and commercializing drug products based on its patented Thin Film Freezing (TFF) technology platform in the United States and Australia. It intends to focus on the development of inhaled dry powder drugs for the treatment of pulmonary diseases and condit...

Get notified when there are updates to the investment portfolio of Corriente Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Corriente Advisors, LLC with notifications on news.